IP Library Granted Patent US 8,372,986
Granted Patent B2
US 8,372,986 · App. 11/992,696 · Granted Feb 12, 2013

Ruthenium-catalyzed cycloaddition of alkynes and organic azides

Inventors: Valery Fokin (Oceanside, CA); Guocheng Jia (Kowloon, HK); K. Barry Sharpless (La Jolla, CA)
Assignees: The Scripps Research Institute; The Hong Kong University of Science and Technology
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,372,986
App. No.
11/992,696
Granted
Feb 12, 2013
Kind
B2
Abstract

A convenient process for the regioselective synthesis of 1,5-disubstituted 1,2,3-triazoles and 1,4,5-trisubstituted 1,2,3-triazoles from organic azides and alkynes employs catalytic ruthenium.

Claims (35)

1. A process for the formation of a 1,5-disubstituted 1,2,3-triazole or 1,4,5-trisubstituted 1,2,3-triazole, the process comprising the following steps:

Step A: admixing a first compound having an acetylene group with a second compound having an azide group in a solvent for forming a reaction mixture wherein the azide group is bonded to an aliphatic carbon in the second compound; and then

Step B: contacting the reaction mixture of said Step A with a quantity of ruthenium catalyst sufficient for catalyzing the formation of the 1,5-disubstituted 1,2,3-triazole or the 1,4,5-trisubstituted 1,2,3-triazole, wherein the ruthenium catalyst comprises Ru(II) bearing a cyclopentadienylic ligand;

with the following provisos:

if the first compound is a terminal acetylene, then the product will be a 1,5-disubstituted 1,2,3-triazole; and

if the first compound is an internal acetylene, then the product will be a 1,4,5-trisubstituted 1,2,3-triazole.

2. The process according to claim 1 wherein the ruthenium catalyst is selected from the group consisting of Cp*RuCl(PPh 3 ) 2 , [Cp*RuCl 2 ] 2 , Cp*RuCl(NBD), and Cp*RuCl(COD), wherein Cp* is pentamethylcyclopentadienyl, NBD is norbornadienyl, and COD is cyclooctadienyl.

3. The process according to claim 1 wherein the solvent is selected from the group consisting of: benzene, toluene, tetrahydrofuran, and dioxane.

4. A method for preparing a 1,2,3-triazole comprising contacting an alkyne and an organic azide compound in a solvent with a ruthenium-based catalyst for a period of time sufficient to form a 1,2,3-triazole compound from the alkyne and the azide; wherein the ruthenium-based catalyst comprises Ru(II) bearing a cyclopentadienylic ligand.

5. The method of claim 4 wherein the cyclopentadienylic ligand is pentamethylcyclopentadienyl.

6. The method of claim 5 wherein the ruthenium-based catalyst is selected from the group consisting of bis-triphenylphosphino pentamethylcyclopentadienyl ruthenium (II) chloride, bis-[pentamethylcyclopentadienyl ruthenium (II) chloride], norbornadienyl pentamethylcyclopentadienyl ruthenium (II) chloride, and cyclooctadienyl pentamethylcyclopentadienyl ruthenium (II) chloride.

7. The method of claim 4 wherein the catalyst comprises cyclopentadienyl bis-triphenylphosphino ruthenium (II) chloride.

8. The method of claim 4 wherein the solvent is an aprotic solvent.

9. The method of claim 8 wherein the aprotic solvent comprises at least one solvent selected from the group consisting of benzene, toluene, tetrahydrofuxan, and dioxane.

10. The method of claim 4 wherein the alkyne and the organic azide are each present in the solvent at a concentration in the range of about 0.01 M to 1 M.

11. The method of claim 4 wherein the ruthenium-based catalyst is present in the solvent at a concentration in the range of about 1 to about 5 mol % based on the moles of alkyne or azide present.

12. The method of claim 4 wherein the solvent is maintained at a temperature in the range of about ambient room temperature to reflux temperature.

13. The method of claim 4 wherein the catalyst comprises a pentamethylcyclopentadienyl ruthenium (II) compound bearing a substituent selected from the group consisting of halide, alkylsulfonate, arylsulfonate, and cyanide.

14. The method of claim 4 wherein the alkyne is bonded to a radical selected from the group consisting of hydrogen, alkyl, alkenyl, aryl, heteroaryl, benzyl, propargyl, cycloalkyl, trialkylsilyl, alkyldiarylsilyl, dialkyiarylsilyl, trialkylstannyl, triarylsilyl, and cycloalkenyl.

15. The method of claim 4 wherein the organic azide is an aliphatic azide.

16. The method of claim 15 wherein the aliphatic azide is selected from the group consisting of a primary aliphatic azide, a tertiary azide, a benzylic azide and mixtures thereof.

17. A method for preparing a 1,5-disubstituted-1,2,3-triazole comprising contacting a terminal alkyne and an organic azide compound in a solvent with a ruthenium-based catalyst for a period of time sufficient to form a 1,5-disubstituted-1,2,3-triazole compound from the alkyne and the azide; wherein the ruthenium-based catalyst comprises Ru(II) bearing a pentamethylcyclopentadienyl ligand.

18. The method of claim 17 wherein the ruthenium-based catalyst is selected from the group consisting of bis-triphenylphosphino pentamethylcyclopentadienyl ruthenium (II) chloride, bis-[pentamethylcyclopentadienyl ruthenium (II) chloride], norbornadienyl pentamethylcyclopentadienyl ruthenium (II) chloride, and cyclooctadienyl pentamethylcyclopentadienyl ruthenium (II) chloride.

19. The method of claim 17 wherein the organic azide is a primary aliphatic azide, a tertiary azide or a benzylic azide.

20. The method of claim 17 wherein the solvent is an aprotic solvent.

21. The method of claim 17 wherein the alkyne and the organic azide are each present in the solvent at a concentration in the range of about 0.01 M to 1 M.

22. The method of claim 17 wherein the ruthenium-based catalyst is present in the solvent at a concentration in the range of about 1 to about 5 mol % based on the moles of alkyne or azide present.

23. A method for preparing a 1,4,5-trisubstituted-1,2,3-triazole comprising contacting an internal alkyne and an organic azide compound in a solvent with a ruthenium-based catalyst for a period of time sufficient to form a 1,4,5-trisubstituted-1,2,3-triazole compound from the alkyne and the azide; wherein the ruthenium-based catalyst comprises Ru(II) bearing a pentamethylcyclopentadienyl ligand.

24. The method of claim 23 wherein the ruthenium-based catalyst is selected from the group consisting of bis-triphenylphosphino pentamethylcyclopentadienyl ruthenium (II) chloride, bis-[pentamethylcyclopentadienyl ruthenium (II) chloride], norbornadienyl pentamethylcyclopentadienyl ruthenium (II) chloride, and cyclooctadienyl pentamethylcyclopentadienyl ruthenium (II) chloride.

25. The method of claim 23 wherein the organic azide is a primary aliphatic azide, a tertiary azide or a benzylic azide.

26. The method of claim 23 wherein the solvent is an aprotic solvent.

27. The method of claim 23 wherein the alkyne and the organic azide are each present in the solvent at a concentration in the range of about 0.01 M to 1 M.

28. The method of claim 23 wherein the ruthenium-based catalyst is present in the solvent at a concentration in the range of about 1 to about 5 mol % based on the moles of alkyne or azide present.

29. The method of claim 23 wherein the solvent is maintained at a temperature in the range of about ambient room temperature to reflux temperature.

30. The method according to claim 23 wherein the ruthenium catalyst is bis-triphenylphosphino pentamethylcyclopentadienyl ruthenium (II) chloride.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 16, 2015
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 037302/0419 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 28, 2010
From: FOKIN, VALERY; SHARPLESS, K. BARRY; JIA, GUOCHENG
To: THE SCRIPPS RESEARCH INSTITUTE; THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
Reel/Frame 024753/0728 →
CONFIRMATORY LICENSE Recorded Jun 11, 2009
From: SCRIPPS RESEARCH INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022812/0509 →
Continuity (2)
Provisional Application 60722488 · Sep 30, 2005
Related Publication 20100286405A1 · Nov 11, 2010